GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
NANOG | 20857 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.5461 | 30254465
|
NANOG | 20857 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.5461 | 32953511
|
NANOG | 20857 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.5461 | 27633248
|
POU5F1 | 9221 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.6448 | 32953511
|
POU5F1 | 9221 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.6448 | 27633248
|
POU5F1 | 9221 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by IF staining | NA | 0.48 | 0.6448 | 24101104
|
SOX2 | 11195 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.5695 | 30254465
|
SOX2 | 11195 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.5695 | 32953511
|
CD44 | 1681 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | FACs followed by SFA and IF staining | NA | 0.36 | 1 | 23681228
|
CD44 | 1681 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Western Blotting | NA | 0.36 | 1 | 27633248
|
CD44 | 1681 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Tumorigenicity assay and IF staining | NA | 0.36 | 1 | 22521544
|
CD44 | 1681 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SP assay followed by FACs | NA | 0.36 | 1 | 22825470
|
PROM1 | 9454 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | FACs followed by SFA and IF staining | NA | 0.36 | 0.7582 | 23681228
|
PROM1 | 9454 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | MACs followed by SFA and IF staining | NA | 0.36 | 0.7582 | 23456479
|
PROM1 | 9454 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | Cisplatin | RT-PCR and FACs | NA | 0.36 | 0.7582 | 21174061
|
PROM1 | 9454 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | Taxinol | RT-PCR and FACs | NA | 0.36 | 0.7582 | 21174061
|
PROM1 | 9454 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Western Blotting | NA | 0.36 | 0.7582 | 30015975
|
PROM1 | 9454 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | MACs and FACs followed by SFA | NA | 0.36 | 0.7582 | 30542415
|
PROM1 | 9454 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Tumorigenicity assay and IF staining | NA | 0.36 | 0.7582 | 22521544
|
PROM1 | 9454 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | MACs followed by SFA and Tumorigenicity assay | NA | 0.36 | 0.7582 | 27633248
|
PROM1 | 9454 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by FACs | NA | 0.36 | 0.7582 | 26871945
|
PROM1 | 9454 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SP assay followed by FACs and SFA | NA | 0.36 | 0.7582 | 22825470
|
ABCG2 | 74 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | Cisplatin | RT-PCR followed by FACs | NA | 0.32 | 0.1739 | 21174061
|
ABCG2 | 74 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | Taxinol | RT-PCR followed by FACs | NA | 0.32 | 0.1739 | 21174061
|
PLAUR | 9053 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by FACs and qRT-PCR | NA | 0.32 | 0.0085 | 30254465
|
PLAUR | 9053 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Western Blotting | NA | 0.32 | 0.0085 | 30015975
|
PLAUR | 9053 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Tumorigenicity assay and IF staining | NA | 0.32 | 0.0085 | 22521544
|
PLAUR | 9053 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | FACs | NA | 0.32 | 0.0085 | 27167619
|
THY1 | 11801 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by FACs and qRT-PCR | NA | 0.32 | 0.0371 | 24101104
|
THY1 | 11801 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by FACs | NA | 0.32 | 0.0371 | 24101104
|
ALDH1A1 | 402 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.684 | 27633248
|
ALDH1A1 | 402 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SP assay followed by ALDEFLUOR assay | NA | 0.28 | 0.684 | 22825470
|
ENO2 | 3353 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0042 | 35487890
|
CXCL2 | 4603 | HTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0074 | 30254465
|
IGFBP3 | 5472 | HTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0095 | 30254465
|
MIR149 | 31536 | HTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0021 | 23117485
|
MIR21 | 31586 | HTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0085 | 23117485
|
MIR30B | 31625 | HTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0053 | 23117485
|
MIRLET7B | 31479 | HTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0042 | 23117485
|
SPINK6 | 29486 | HTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0042 | 30254465
|
ST3GAL5 | 10872 | HTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0021 | 30254465
|
IL8 | 6025 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by qRT-PCR and Migration and Invasion assay | NA | 0.2 | 0.0159 | 30254465
|
CD24 | 1645 | LTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SP assay followed by FACs | NA | 0.12 | 0.456 | 22825470
|
MIR125A | 31505 | HTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 23117485
|
MIR125B1 | 31506 | HTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 23117485
|
MIR1469 | 35378 | HTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 23117485
|
MIR146A | 31533 | HTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 23117485
|
MIR15B | 31544 | HTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0085 | 23117485
|
MIR16-1 | 31545 | HTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 23117485
|
MIR1915 | 35399 | HTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 23117485
|
MIR20B | 32024 | HTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 23117485
|
MIR23B | 31606 | HTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 23117485
|
MIR23C | 38913 | HTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 23117485
|
MIR27A | 31613 | HTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 23117485
|
MIR2861 | 38221 | HTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 23117485
|
MIR30C1 | 31626 | HTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 23117485
|
MIR3141 | 38326 | HTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 23117485
|
MIR3178 | 38381 | HTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 23117485
|
MIR3185 | 38391 | HTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 23117485
|
MIR3621 | 38930 | HTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 23117485
|
MIR4281 | 38357 | HTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23117485
|
MIR483 | 32340 | HTM | Small Cell Lung Cancer | Carcinoma | H446 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 23117485
|